Enlarged Board of Appeal fails to offer clear guidance in highly-anticipated “plausibility” opinion
The EBA has not laid out clear rules about when post-filed evidence can be used to demonstrate technical effect
The EBA has not laid out clear rules about when post-filed evidence can be used to demonstrate technical effect
The Munich Regional Court has clarified its stance on the hot topic in German patent litigation, ruling on the new defence in three parallel SEP cases, providing welcome clarity for future litigation strategies.
While the codification of remote hearings, a triple exchange of briefs and the simplification of procedures may present new challenges, these new reforms should ultimately bring about positive changes to the justice system by streamlining and modernising procedures.
Director General José Sánchez Pérez meets with local lawyers to discuss enforcement and implementation of IP law
25 January 2023
The heavily debated concept of plausibility is quickly gaining prominence in invalidity proceedings. While it remains to be seen how the EPO will cement the concept into case law, several key existing cases present a number of conflicting arguments on the issue.
25 January 2023
Taiwan’s Intellectual Property Case Adjudication Act is being amended in order to strengthen the protection of trade secrets and modernise the country’s IP litigation system.
25 January 2023
Individual inventors and innovative small businesses have a compelling story to tell about a system that does not work for them, but it has yet to hit home
19 January 2023
America risks losing ground in the next tech revolution he warns in an interview with Burford Capital Managing Director Katharine Wolanyk
17 January 2023
Commission may face legal challenges but risks of trade secrets breaches and increased litigation abound
13 January 2023
Move could see ‘temporary paralysis’ at INPI
12 January 2023
A string of deals announced during December and the beginning of January send a very clear message to policymakers and regulators
12 January 2023
The court rejected Juno Therapeutics’ appeal, despite claims of similarity with Amgen v Sanofi dispute
11 January 2023
Kathi Vidal will conduct a sua sponte review in Samsung vs Netlist and issued updates on VLSI IPR abuse reviews
06 January 2023
Unlock unlimited access to all IAM content